Flowers Lee's Form 4 filing
HCW Biologics Inc. (HCWB) · filed Jun 9, 2023
- Accession no.
- 0001209191-23-036087
- Filed
- Jun 9, 2023, 8:00 PM ET
- Trade date
- Jun 8, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market purchases total $21.6K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Flowers LeeCIK 0001866254 | Officer (SVP of Business Development) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 8, 2023 | Common Stock | MOption exerciseAcquired | +5,356 | $0.14 | +$749.84 | 101,308 | Direct | |
| Jun 8, 2023 | Common Stock | PPurchaseAcquired | +10,000 | $2.16 | +$21,574 | 111,308 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 8, 2023 | Common Stock | MOption exerciseDisposed | −5,356 | $0.00 | $0 | 7,501 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.